David R. W. Jayne MD, FRCP, FRCPE, FMedSci
Professor of Clinical Autoimmunity, University of Cambridge; Director, Vasculitis and Lupus Clinic. Addenbrooke’s Hospital, Cambridge, United KingdomDr. David R. W. Jayne has been Professor of Clinical Autoimmunity in the Department of Medicine at the University of Cambridge since 2017. Dr. Jayne is a medical advisor to UK, U.S. and EU regulatory bodies, patient groups, and professional organizations. His work has been published in more than 500 peer-reviewed journal articles, book chapters, and reviews. He was elected the first President of the European Vasculitis Society in 2011 and co-chairs the EULAR task force on lupus nephritis. Dr. Jayne’s research includes investigator-initiated international trials and the introduction of newer therapies in vasculitis and SLE with collaborators on five continents. In 2021 he received the European Renal Association award for outstanding contribution to nephrology.
Dr. Jayne received his MB BChir in Surgery and Medicine from Cambridge University. He received postgraduate training at several London hospitals and Harvard University. He is a fellow of the Royal College of Physicians of London and Edinburgh, and the Academy of Medical Science. He is a certified nephrologist and an Honorary Consultant Physician at Addenbrooke’s Hospital, Cambridge, UK.
Disclosures
Dr. Jayne reports the following:Personal fees:
- Consultancy: Astra-Zeneca, BMS, Boehringer-Ingelheim, Chemocentryx, GSK, NICE, Novartis, Otsuka, Roche/Genentech, Takeda, UCB & Vifor
- Lecture fees: Amgen, Kessai, Vifor
- Board Member and stock options: Aurinia
- Commercial: GSK, Roche/Genentech
- Non-commercial: EU, MRC, NIHR, Versus Arthritis